FDA Inspection
Sunshine Lake Pharma Co., LtdSunshine Lake Pharma Co., Ltd – FDA Inspection, Aug 9, 2019
Record Details
This FDA Inspection record concerns Sunshine Lake Pharma Co., Ltd, with an inspection on August 9, 2019, issued by the Office of Inspections and Investigations, covering human drugs.
- People
- Kara D. Dobbin (Issuing Officer)
- Ruo H. Xu (Issuing Officer)
View Company Profile
ID · 8209913c-c209-4068-8d4b-1b8fb088a353
Inspection Facts
- Inspection number
- 1106395
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Sunshine Lake Pharma Co., Ltd
7| Date | Classification | Office | Project area |
|---|---|---|---|
| March 22, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 25, 2019 | VAI | Office of Inspections and Investigations | Generic Drug Evaluation |
| March 16, 2018 | Not classified | Office of Inspections and Investigations | |
| October 19, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 25, 2015 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Sunshine Lake Pharma Co., Ltd
- FDA Inspection 1236240 - 2024-03-22
- FDA Inspection 1078090 - 2019-01-25
- FDA Inspection 1046748 - 2018-03-16
- FDA Inspection 1030492 - 2017-10-19
- FDA Inspection 945450 - 2015-09-25
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.